what does semaglutide look like GLP-1s PDB-101: Diabetes Mellitus: Diabetes Mellitus:

The addition of GIPR activity was the key pharmacological innovation of tirzepatide, enabling greater weight loss than pure GLP-1 agonism

A recent example is the pull-out of Tresiba from Germany due to the pricing pressure after the authorities said they would price the long-acting basal insulin on par with old human insulin injections

2021;13(11):e20041

#Pharmacology #Gastroenterology #Medicine #ClinicalPharmacology #PPIs #GERD #PepticUlcer #MedicalEducation #Healthcare #DrugMechanism #EvidenceBasedMedicine To view or add a comment, sign in Here it is our major consensus statements regarding fatty liver (#MASLD), published previously

Now, oral GLP-1s for weight loss are available